Determining the order of every base in an organism's genome. Differs from genotyping, which only looks at a specific subset of genetic variants.
Genomics England's Newborn Genomes Programme will explore the benefits, practicalities, and challenges of whole genome sequencing for newborn babies in the UK. The genomic data will be used to develop diagnostics and treatments for hundreds of diseases, particularly rare conditions…
Analysing genetic pathways linked to metabolism has moved researchers one step closer to understanding the genetics of obesity...
The Progress Educational Trust's last event of 2021 continued the discussion about using whole genome sequencing in newborn babies...
The fourth session of the Progress Educational Trust's 2021 annual conference explored the dilemmas regulators face when trying to create legislation to safeguard fertility treatment and embryo research...
Questions submitted by participants in a recent Progress Educational Trust event are answered by the body that oversees newborn screening in the UK...
A new pilot study embedded in the NHS will explore whether and how to offer whole genome sequencing to newborn babies...
The first 200,000 whole genomes to be sequenced as part of the UK Biobank project have been made widely available to researchers...
Whole genome sequencing of NHS patients with rare diseases can provide diagnoses that could lead to more personalised care or treatment and potentially save the NHS money, a study has shown...
Outcomes for child cancer patients could be dramatically improved by sequencing their genomes, a study has shown...
Currently, only nine conditions are screened for in the UK, which is fewer than many other high-income countries. Although many patient groups advocate for new conditions to be added to the list, this has not happened...
Subscribe for free to what PET does best – informing you of the latest in fertility, genomics and embryo research.
